BlueRemediomics researcher Professor Marcel Jaspars from the University of Aberdeen has co-authored a new article in Nature Biotechnology titled “From frameworks to finance: how sharing benefits from

On June 20, as part of their public engagement and Town Hall series, our partners from the University of Aberdeen and the Latvian Biomedical Research and Study Center

The International Marine Biotechnology Conference (IMBC) is a major global event centred on marine biotechnology, gathering the sector’s experts since 1989. This year, it took place in

Last month, BlueRemediomics partners came together for three days in the Latvian capital to present updates and discuss the project’s progress and challenges. Hosted by

BlueRemediomics partners from the University of Aberdeen and ABS International/3BIO co-organised a workshop on Article 12 of the Agreement and served as Rapporteurs during the BBNJ Symposium in Singapore

Originally published by CORDIS.  Can seaweed help reduce inflammation in farmed fish? An EU-backed study investigates.  A recent study carried out by Norwegian and Spanish researchers explores

February 20 is World Day of Social Justice, an opportunity to show how BlueRemediomics partners are working to improve Access and Benefit-Sharing (ABS), to ensure

More than twenty researchers from across the world have come together to publish a collaborative book, ‘Decoding Marine Genetic Resource Governance Under the BBNJ Agreement’,

Return of the schooner Tara and the EMBL mobile laboratory after an unprecedented 18-month land-sea expedition On October 5th 2024, the scientific schooner Tara returned

The concept of “doing no significant harm” runs through the EU Horizon Europe project BlueRemediomics, and has been explored in the past in “Town Hall”